AMGEN REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS
Revenue$10.1 billion+10% YoY
EPS$2.65
Collected automatically from companies' SEC filings (Form 8-K, Item 2.02)
Forensic equity research on US stocks. No spam, unsubscribe anytime.